22q11.2 Deletion Syndrome, Autism Spectrum Disorder, Autism Spectrum Disorder (ASD, Cerebral Palsy (CP), Cerebral Palsy, Dyskinetic, Cerebral Palsy Hemiparetic Cerebral Palsy Spasticity Gait Disorders, Neurologic Postural Balance Impairment, Cerebral Palsy Infantile, Cerebral Palsy Spastic Hemiplegic, Chromosomal Abnormalities, Developmental Delay (Disorder), Down Syndrome (Trisomy 21), Fragile X Syndrome (FXS), Genetic Disorders, Hypoxic Ischemic Encephalopathy, Hypoxic Ischemic Encephalopathy (HIE), Neurodevelopmental Disorders, Neurodevelopmental Disorders and Developmental Abnormalities, Neurodevelopmental Disorders (NDD), RETT Syndrome With Proven MECP2 Mutation, Sensorimotor Integration, Sensory Processing Disorder, Traumatic Brain Injury (TBI), Williams Syndrome
Conditions
Keywords
Photobiomodulation, Low-Level Laser Therapy, Vibration Therapy, Tactile Stimulation, Cognitive Training, Behavioral Therapy, Intensive Therapy, Pediatric Neurorehabilitation, Multimodal Therapy, Neuroplasticity, Sensory Integration, Reflex Integration, Motor Planning, Executive Function, Emotional Regulation, Functional Outcomes, Activities of Daily Living, High Frequency Therapy, Neurodevelopmental Disorders, Rehabilitation, Child Development Disorders, Occupational Therapy, Physical Therapy Modalities, Early Intervention, Cognitive Therapy
Brief summary
This observational study evaluates functional and developmental outcomes in pediatric participants undergoing a two week intensive multimodal neurorehabilitation program. The program is designed for children with neurodevelopmental disorders, including but not limited to cerebral palsy, autism spectrum disorder, developmental delay, hypoxic ischemic encephalopathy (HIE), and chromosomal or genetic abnormalities. Participants receive individualized therapy sessions for approximately 2.5 hours per day over a two week period. The intervention is not standardized but is tailored to each child's specific needs and may include components such as sensory integration, motor planning, reflex integration, oculomotor training, executive functioning activities, communication support, and other brain based therapeutic approaches. The purpose of this study is to observe changes in functional abilities, including attention, motor coordination, emotional regulation, communication, and activities of daily living. Outcomes are assessed using clinician observation and parent reported changes before and after the intensive program, with limited follow-up when available. This study does not assign participants to a specific treatment as part of a research protocol. Instead, it collects real world data from children already participating in a clinical therapy program to better understand potential benefits of intensive, individualized neurorehabilitation approaches.
Detailed description
Children with neurodevelopmental disorders often present with complex impairments affecting motor function, sensory processing, communication, attention, emotional regulation, and daily living skills. These conditions may arise from acquired neurologic injury (such as hypoxic ischemic encephalopathy or traumatic brain injury) or from genetic and chromosomal abnormalities (such as Down syndrome, Rett syndrome, or other genomic disorders). Traditional therapy models delivered at low frequency may not fully address the intensity required to drive meaningful neuroplastic change. Intensive, high frequency, and multimodal rehabilitation approaches have been proposed as a strategy to enhance neural adaptation by increasing repetition, engagement, and cross-modal stimulation within a short time period. This observational study is designed to systematically characterize real world outcomes associated with a two week pediatric intensive therapy model that integrates multiple therapeutic modalities tailored to the individual child. This is a prospective observational study of pediatric participants enrolled in an intensive therapy program. No randomization or experimental intervention is introduced as part of the study. All therapies are delivered as part of routine clinical care. Participants attend therapy sessions for approximately 2.5 hours per day, 5 days per week, for 2 consecutive weeks. Therapy is individualized and may include a combination of: * Sensory integration techniques * Motor planning and coordination activities * Reflex integration exercises * Oculomotor and visual processing training * Auditory processing activities * Executive functioning tasks * Communication support strategies * Emotional regulation training * Brain based and neurodevelopmental exercises Additional modalities such as vibration, tactile stimulation, and photobiomodulation may be used at the discretion of the treating clinician. This study aims to generate real world evidence on the potential benefits of intensive, individualized, multimodal neurorehabilitation in children with complex neurodevelopmental conditions, including those with genetic and chromosomal etiologies. Findings may inform future controlled studies and help guide clinical decision making for therapy intensity and program design.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Pediatric participants between approximately 4 and 12 years of age at the time of enrollment. * Diagnosed with or presenting with neurodevelopmental, neurologic, or genetic conditions, including but not limited to: * cerebral palsy * autism spectrum disorder * developmental delay * hypoxic ischemic encephalopathy (HIE) * traumatic brain injury * sensory processing disorder * chromosomal or genetic abnormalities * Demonstrate functional impairments in one or more neurodevelopmental domains, including: * motor coordination or motor planning * sensory processing * attention or executive functioning * oculomotor or visual processing * communication * emotional or behavioral regulation * activities of daily living * Enrolled in and able to participate in a two-week intensive therapy program consisting of approximately 2.5 hours per day/ 5 days per week * Able to complete baseline and post-program clinical assessment using clinician-observed or caregiver-reported measures. * Parent or legal guardian able to provide informed consent and participate in reporting functional outcomes when applicable.
Exclusion criteria
* Medical instability or acute medical condition that would prevent safe participation in an intensive therapy program. * Severe uncontrolled seizure activity or other neurologic condition that would interfere with participation in structured therapeutic activities, as determined by the treating clinician. * Behavioral or psychological conditions that would prevent safe engagement in the therapy environment despite appropriate support. * Inability to attend or complete the full two-week intensive program. * Lack of sufficient baseline or post-intervention data to assess change in functional performance. * Concurrent participation in another structured intervention or clinical study that would confound interpretation of functional outcomes, at the discretion of the investigator.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Clinician Assessed Functional Neurodevelopmental Performance | Baseline to end of 2 week intensive program | Within participant change from baseline to completion of the 2 week intensive program in individualized clinician assessed neurodevelopmental performance domains used in routine care. Measures may include neural timing accuracy in milliseconds relative to metronome paced motor tasks, oculomotor performance scored by saccadic eye movements and horizontal pursuits, primitive reflex integration scored on a 0-5 scale, processing speed/visual scanning completion time, bilateral coordination, crossing midline, sustained attention duration, tactile or stimulation tolerance, executive functioning, emotional regulation, communication intent, and participation in non preferred activities. Each participant is assessed only on domains relevant to their presentation, consistent with the source document's individualized assessment model. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in Neural Timing Accuracy | Baseline to end of 2 week intensive program | Change in neural timing performance during metronome paced motor sequencing tasks, recorded as milliseconds from target rhythm and/or number of steps completed at target accuracy. |
| Change in Oculomotor Control | Baseline to end of 2 week intensive program | Change in oculomotor performance assessed by clinician-scored saccadic eye movements and horizontal pursuits, recorded as number correct out of 16 when applicable. |
| Change in Primitive Reflex Persistence | Baseline to end of 2 week intensive program | Change in primitive reflex persistence or integration assessed by clinician rating on a 0 to 5 scale and/or reflex status. Reflexes assessed may include TLR, ATNR, STNR, MORO, Rooting, Palmar, Spinal Galant, Spinal Perez, and Babkin, depending on participant presentation. |
| Change in Processing Speed and Visual Scanning Time | Baseline to end of 2-week intensive program | Change in processing speed and visual scanning measured by time to complete structured scanning tasks. Depending on participant presentation, tasks may include color, number, word, color-word, 69 arrows, and BD69 scanning activities, as well as sorting number/shape/color. Lower completion time indicates improvement. |
| Change in Bilateral Word Taps and Cross Midline Performance | Baseline to end of 2-week intensive program | Change in bilateral word tap performance measured by time to complete assigned 100 series or 200 series pages, with notation of cueing needs for crossing midline when applicable. |
| Change in Attention, Activity Tolerance, and Participation in Non Preferred Activities | Baseline to end of 2 week intensive program | Change in ability to sustain engagement in therapeutic activity and participate in non preferred tasks, measured by clinician observation using duration in minutes, percentage of participation, and/or required level of assistance. |
| Change in Emotional Self Regulation | Baseline to end of 2 week intensive program | Change in emotional regulation or self regulation assessed by clinician rated delay severity, ability to identify feelings, behavioral response during challenge, and/or level of assistance required for regulation and transitions. |
| Parent Reported Functional Carryover and Retention of Gains | Up to 4 weeks after completion of the intensive program | Parent or caregiver reported change in daily functioning after the intensive, including independence in morning or bedtime routines, self care, mealtime behavior, reading speed, communication, community outings, emotional regulation, problem solving, and retention of gains. |
Countries
United States
Contacts
Board Certified Pediatric Therapist Executive Director Ability and Beyond Integrated Therapies